Backed by Science

Medical Cannabis

The healing properties of cannabis have been known for thousands of years. 

Cannabis has been used for medical purposes as a treatment for 3,000 years in various cultures. Historical evidence suggests that doctors have been mixing cannabis with various medicines to treat pain and other ailments.

Today, cannabis finds application in a wide range of medical conditions, with its medicinal use being mainly associated with relieving from physical and mental difficulties, as well as keeping the body in balance.

Medicinal cannabis is used among others for, for reduceing spasticity in patients with multiple sclerosis,and it is indicated for the prevention and treatment of nausea and / or hyperemesis due to chemotherapy, . Moreover, it contributes to the treatment of chronic neuropathic pain and the palliative care of patients in the final stages of cancer.

Τhe use of medicinal cannabis was legalized in Greece, in 2017, while in March 2018, the legal framework was created for its cultivation, processing, marketing and export. Currently, the production and distribution of finished medicinal cannabis products with a tetra-hydrocannabinol (THC) content of more than 0.2% is allowed for purely medical purposes either internally or for export. The mode of action of formulations containing cannabinoids is based on the physiological mechanisms of the Endocannabinoid System (ECS).

Endocannabinoid System

anthropas noshadow 01

It is a complex network of receptors, signaling molecules (endocannabinoids) and enzymes. ECS was discovered rather recently. Although the molecules of THC and CBD (phytocannabinoids) have been isolated as early as the 60s and their structures have been elucidated by Dr. Raphael Mechoulam, the mechanism through which these molecules exerted their action remained unknown. It was not until 1988, that it was found that the brain of mammals express receptors which respond to cannabis components. A few years later, the receptors CB1 and CB2 of the ECS were cloned, while in 1992, the endocannabinoid molecule anandamide was isolated for the first time, once again from the laboratory of Dr. Mechoulam. Dr. Mechoulam's findings were the starting point for scientific research and clinical studies on the therapeutic uses of the cannabis plant and served as the scientific basis for the establishment of Tikun Olam in 2002.

Regarding the role of the ECS, well-established evidence shows that it plays an important role in human health and well-being. It serves the essential function of restoring homeostasis through physiological and regulatory mechanisms. Its effectiveness is enhanced by the intake of cannabinoids and their interaction with the ECS receptors. The beneficial effect of cannabinoids is supported by a large number of bibliographic references. Cannabinoids potentially help relieve pain, manage stress, improve mood, increase appetite and energy. In addition, they help reduce nausea and enhance the immune system.

.

Live with CBD

[Cannabidiol]

A non-psychoactive, non-addictive substance which belongs to the main cannabinoid family.
CBD is associated with beneficial outcomes that support balance and well-being and helps in everyday discomforts.
It is used any time of the day.

Tikun & Community Research

Bitmap


Tikun Olam based in Israel is a proud pioneer and global leader in medical cannabis research. Rooted in Israel's regulatory environment, Tikun Olam’s team of scientists have been studying medical cannabis and performing clinical trials for more than a decade, achieving outstanding results and amassing one of the world's largest database of patients under medical cannabis treatment numbering currently more than 20,000 patients.
Through extensive research and development, Tikun Olam's proprietary strains have been genetically optimized and clinically proven to provide symptomatic relief for a wide variety of ailments, including nausea/ hyperemesis from chemotherapy, neuropathic and chronic pain, spasticity in MS and more. Achievements on the clinical field have encouraged Tikun to devote additional resources to further improve its products, as well as to better understanding of the therapeutic properties of the cannabis plant.
Tikun conducts laboratory studies (both in vitro and in vivo), retrospective analyses, and clinical trials, and works diligently to follow-up with patients.

Tikun Strains

Tikun Europe’s medical cannabis is grown using high-level scientific techniques. It owns the exclusive use of award-winning strains that have been genetically modified to maximize symptomatic relief. Specifically for the development of its medical formulations, Tikun Europe has selected, from a range of Tikun Olam Israel cannabis strains, the ones that cover the widest range of medical conditions for which there is documented efficacy, based on clinical studies.

Shape 1
Avidekel

Avidekel is an Indica strain. Medical cannabis products of the Avidekel strain are recommended for administration both during the day and during the night.
This strain has been created using the recombinant DNA technology to express high levels of CBD and very low levels of THC. The CBD content in the dry flower may reach 19%. Avidekel formulations have been clinically tested in Israel in patients with pain, autism, Crohn's disease, and other digestive disorders. Improvement of patients’ quality of life has been proven. The effectiveness of Avidekel products has been positively evaluated in Israel for relieving symptoms in inflammatory conditions, inflammatory pain, and convulsions.

 



suitable for day / night care

 


Shape 1
Midnight

Midnight is a hybrid strain. It is recommended for administration both during the day and during the night. The plant expresses both THC and CBD in balanced ratio. The Midnight dry flower has a THC and CBD content of 12-14%. Midnight formulations have been positively evaluated in Israel for treating pain, nausea and vomiting from the administration of chemotherapeutic agents, for anxiety, depression, and as appetite stimulants.

 


 

 suitable for day / night care

 


 

Shape 1
Alaska

Alaska is a sativa strain. It is recommended for administration during the day. The Alaska plant expresses high levels of THC and very lower levels of CBD. The dry flower has a THC content of 16-22%. Alaska formulations have been evaluated in Israel for treating pain, nausea and vomiting from the administration of chemotherapeutic agents, and as appetite stimulants. 





 suitable for day care

 


Shape 1
Erez

Erez is an Indica Strain. It is recommended for administration at night. The plant is characterized of high THC content and low CBD. The Erez dry flower has a THC content of 20-24%. Erez formulations have been evaluated in Israel for the treatment of pain, nausea and vomiting from the administration of chemotherapeutic agents, spasticity, sleep disorders and as appetite stimulants.




suitable for day / night care

 


Tikun Strains

Tikun Europe’s medical cannabis is grown using high-level scientific techniques. It owns the exclusive use of award-winning strains that have been genetically modified to maximize symptomatic relief. Specifically for the development of its medical formulations, Tikun Europe has selected, from a range of Tikun Olam Israel cannabis strains, the ones that cover the widest range of medical conditions for which there is documented efficacy, based on clinical studies.

Shape 1
Avidekel

Indica Dominant Strain

 
Tikun's most researched and award-winning strain. Containing virtually no THC, reaching a content of up to 19% in CBD, has been clinically proven to help treat pain, autism, Crohn's disease and other digestive disorders. Avidekel is ideal for patients receiving mild treatment that results in relief without the psychoactive effects of THC. This formulation can be beneficial for those seeking relief from Arthritis, Autism, Epilepsy, Fibromyalgia, Migraines, Pain & Inflammation and Seizures.



suitable for day / night care


Shape 1
Midnight

Sativa Dominant Hybrid

 

Midnight balances a near 1:1 ratio of 12-14% THC & CBD. It offers relaxation while the patient remains lucid and functional. This 1:1 variety is an ideal proposition for cases where a balanced effect is required in patients who have no previous experience of treatment with medicinal cannabis Specifically, Midnight is an ideal treatment for relief from Anxiety, Depression, Fibromyalgia, Muscle and Joint Pain, Post Traumatic Stress Syndrome (PTSD) and Horror Attacks.

 



 suitable for day / night care

 


 

Shape 1
Alaska
Sativa Strain The composition of Alaska, is high in THC Sativa (16-22%) Ideal proposal for daytime administration and appropriate proposal for cases where enhanced action is required. Alaska has been shown to effectively relieve nausea, headaches, pain in general, while restoring the body to ideal energy levels and improving overall mood. Alaska is an ideal prescription for those seeking relief from Anxiety, Chronic Pain, Depression, Gastrointestinal Diseases, Nausea and Post-Traumatic Stress Syndrome (PTSD)



 suitable for day care



Shape 1
Erez
The composition of Erez is high in THC concentration up to 20-24%. Erez is indicated for the treatment of sleep disorders, while relieving Pain, Nausea and Inflammation. Erez is also an ideal suggestion for patients seeking chronic pain relief, having Crohn's disease, suffering from Gastrointestinal Diseases, Muscle Spasms, Parkinson's Disease, Post Traumatic Stress Syndrome (PTSD), Sleep Disorders and Horror Crises.



suitable for day / night care



Meet the Experts

Their testimonial

2 layers